Interim safety and efficacy results from AURELIO-03: A phase 1 dose escalation study of the IL-2/IL-15 receptor bg superagonist SOT101 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors.
Pembrolizumab;SOT101
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Interim safety and efficacy results from AURELIO-03: A phase 1 dose escalation study of the IL-2/IL-15 receptor bg superagonist SOT101 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors. ### Output: Pembrolizumab;SOT101